Dicerna Pharmaceuticals/ US2530311081 /
2021-12-27 12:00:00 AM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
38.2200USD | - | 5.57 mill. Turnover: - |
-Bid Size: - | -Ask Size: - | 38.2400 | 38.2100 |
GlobeNewswire
2022-02-02
Community Redevelopment Adds Jeanne Freddura to The Newly Created Position of Senior Vice President ...
GlobeNewswire
2021-12-02
Moore Kuehn Encourages ASPC, ROG, DRNA, and VG Investors to Contact Law Firm
GlobeNewswire
2021-11-18
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Dicerna Pharmaceuticals, Inc.
GlobeNewswire
2021-11-18
DICERNA ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of DRNA and Encourages Investors to Con...
GlobeNewswire
2021-11-18
INVESTIGATION ALERT: Halper Sadeh LLP Investigates DRNA, RC, HFC, EBMT; Shareholders are Encouraged ...
GlobeNewswire
2021-09-14
Scopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Appointments of John Rossi, Ph.D. and ...
GlobeNewswire
2021-04-08
Royalty Pharma Acquires OXLUMO™ Royalty Interest From Dicerna for up to $240 Million
GlobeNewswire
2021-02-02
Protara Therapeutics Announces Appointment of Cynthia Smith to Board of Directors
GlobeNewswire
2020-11-02
Ziopharm Files Definitive Consent Revocation Statement and Sends Letter to Shareholders
GlobeNewswire
2020-10-13
VBL Therapeutics Announces Appointment of Marc Kozin as Vice Chairman of Board of Directors
GlobeNewswire
2019-12-03
Caraway Therapeutics Expands Leadership Team With Appointment of Martin D. Williams, MS, MBA, as Chi...
GlobeNewswire
2019-10-07
Receptor Holdings Expands Board of Directors with Pharmaceutical Industry Business Development Leade...
GlobeNewswire
2019-07-17
RNA Therapy Markets to 2025: Insights Into Kidney Diseases, Cardiovascular, Infectious Diseases, Onc...
GlobeNewswire
2019-06-13
Executive Women In Bio Celebrates the 30th Board Appointment for Boardroom Ready Program Alumnae